Michael Chambers

Michael Chambers

Director/Board Member at SAREPTA THERAPEUTICS, INC.

Net worth: 9 M $ as of 30/06/2026

51 year
Health Technology
Commercial Services
Consumer Services

Profile

Mr. Michael Chambers is an Independent Director at Sarepta Therapeutics, Inc. He is on the Board of Directors at Whitehead Institute for Biomedical Research, Sarepta Therapeutics, Inc., Calviri, Inc., Agathos Biologics LLC and Lykan Biosciences LLC.
Mr. Chambers was previously employed as a Chief Executive Officer & Director by Altravax, Inc. and a Chairman by Aldevron LLC.
He also served on the board at NDSU Research Technology Park, Inc. He received his undergraduate degree from North Dakota State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 5,04,027 ( 0.48% ) 9 M $ 30/06/2026

Michael Chambers active positions

CompaniesPositionStart
SAREPTA THERAPEUTICS, INC. Director/Board Member 02/06/2022
Director/Board Member 18/08/2020
Lykan Biosciences LLC
Director/Board Member -
Director/Board Member 08/12/2022

Former positions of Michael Chambers

CompaniesPositionEnd
Chief Executive Officer 13/07/2020
Director/Board Member -
Founder -
See the detail of Michael Chambers's experience

Training of Michael Chambers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

32

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Lykan Biosciences LLC

  1. Stock Market
  2. Insiders
  3. Michael Chambers